Related Experiment Video
Updated: May 13, 2026

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
Published on: August 22, 2025
Crowdsourcing enables robust cell annotation for breast cancer pathology
Pascal Klöckner1,2,3,4, Melis Erdal Cesur1, Bart de Rooij1
1Computational Pathology group, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
None:
The tumor microenvironment (TME) contains important morphological and molecular cues that help determine prognosis and therapeutic responses. Deep learning models can assist pathologists in assessing such biomarkers. However, generating high-quality annotations for computational pathology remains a significant bottleneck due to the level of expertise and considerable time required for fine-grained labeling. In this study, we evaluate the feasibility of using non-expert crowdsourcing for cell annotation in hematoxylin and eosin (H&E) samples of breast cancer tissue. Unlike prior work, performance assessment was based on high-fidelity ground-truth labels derived from multiplexed immunofluorescence using CODEX data, allowing for accurate benchmarking of both experts and non-experts. We collected cell annotations from experts, semi-experts, and non-experts through Tilly, a gamified annotation application designed to train and engage users in identifying major cell types within the TME. Overall, our results show that non-expert crowdsourcing is a scalable and effective strategy for generating training data for the classification of major cell types in H&E images: tumor cells, lymphocytes, and fibroblasts. Moreover, combining large, crowdsourced datasets with smaller, high-quality subsets annotated using spatial proteomics may offer a practical annotation approach to develop more robust models while minimizing biases.
More Related Videos
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024